{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:16:53Z","timestamp":1788859013170,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40744-024-00678-x","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T08:05:03Z","timestamp":1719993903000},"page":"1115-1134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-1715","authenticated-orcid":false,"given":"Lihi","family":"Eder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-4074","authenticated-orcid":false,"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-663X","authenticated-orcid":false,"given":"Laura C.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-388X","authenticated-orcid":false,"given":"Valderilio F.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-0748","authenticated-orcid":false,"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-3201","authenticated-orcid":false,"given":"Megan","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-3210","authenticated-orcid":false,"given":"Meriem","family":"Kessouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"678_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"678_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69:729\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"678_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:545\u201368.","journal-title":"Rheum Dis Clin North Am"},{"key":"678_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11926-012-0263-5","volume":"14","author":"WJ Taylor","year":"2012","unstructured":"Taylor WJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO international classification of functioning, health, and disability. Curr Rheumatol Rep. 2012;14:369\u201374.","journal-title":"Curr Rheumatol Rep"},{"key":"678_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/acr.20627","volume":"63","author":"JA Husted","year":"2011","unstructured":"Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63:1729\u201335.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"678_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13075-021-02680-y","volume":"24","author":"E Passia","year":"2022","unstructured":"Passia E, Vis M, Coates LC, et al. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther. 2022;24:22.","journal-title":"Arthritis Res Ther"},{"key":"678_CR7","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/acr.24090","volume":"72","author":"A-M Orbai","year":"2020","unstructured":"Orbai A-M, Perin J, Gorlier C, et al. Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with sex in 458 patients from fourteen countries. Arthritis Care Res (Hoboken). 2020;72:1772\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"678_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105177","volume":"88","author":"MT Duruoz","year":"2021","unstructured":"Duruoz MT, Gezer HH, Nas K, et al. Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: a multi-center study. Joint Bone Spine. 2021;88: 105177.","journal-title":"Joint Bone Spine"},{"key":"678_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.220386","volume":"50","author":"LC Coates","year":"2023","unstructured":"Coates LC, van der Horst-Bruinsma IE, Lubrano E, et al. Sex-specific differences in patients with psoriatic arthritis: a systematic review. J Rheumatol. 2023;50:488\u201396.","journal-title":"J Rheumatol"},{"key":"678_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/annrheumdis-2012-201357","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis. 2013;72:578\u201382.","journal-title":"Ann Rheum Dis"},{"key":"678_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12955-020-01422-z","volume":"18","author":"LC Coates","year":"2020","unstructured":"Coates LC, Orbai A-M, Azevedo VF, et al. Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health Qual Life Outcomes. 2020;18:173.","journal-title":"Health Qual Life Outcomes"},{"key":"678_CR12","volume-title":"Fundamentals of biostatistics","author":"B Rosner","year":"2015","unstructured":"Rosner B. Fundamentals of biostatistics. 8th ed. Boston: Cengage Learning; 2015.","edition":"8"},{"key":"678_CR13","volume-title":"Survey sampling","author":"L Kish","year":"1965","unstructured":"Kish L. Survey sampling. New York: John Wiley & Sons; 1965."},{"key":"678_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2217\/ijr.12.63","volume":"7","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Gladman DD. Gender-related differences in patients with psoriatic arthritis. Int J Clin Rheumatol. 2012;7:641\u20139.","journal-title":"Int J Clin Rheumatol"},{"key":"678_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/BOR.0000000000000388","volume":"29","author":"PJ Mease","year":"2017","unstructured":"Mease PJ. Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol. 2017;29:304\u201310.","journal-title":"Curr Opin Rheumatol"},{"key":"678_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002718","volume":"9","author":"L Eder","year":"2023","unstructured":"Eder L, Gladman DD, Mease P, et al. Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension. RMD Open. 2023;9: e002718.","journal-title":"RMD Open"},{"key":"678_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard-2022-222779","volume":"82","author":"S Tarannum","year":"2023","unstructured":"Tarannum S, Widdifield J, Wu CF, Johnson SR, Rochon P, Eder L. Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study. Ann Rheum Dis. 2023;82:283\u201391.","journal-title":"Ann Rheum Dis"},{"key":"678_CR18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpain.2021.03.001","volume":"22","author":"L Zhang","year":"2021","unstructured":"Zhang L, Losin EAR, Ashar YK, Koban L, Wager TD. Gender biases in estimation of others\u2019 pain. J Pain. 2021;22:1048\u201359.","journal-title":"J Pain"},{"key":"678_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045\u201350.","journal-title":"Ann Rheum Dis"},{"key":"678_CR20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/annrheumdis-2012-202608","volume":"72","author":"W Tillett","year":"2013","unstructured":"Tillett W, Jadon D, Shaddick G, et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis. 2013;72:1358\u201361.","journal-title":"Ann Rheum Dis"},{"key":"678_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/annrheumdis-2012-201972","volume":"73","author":"E Theander","year":"2014","unstructured":"Theander E, Husmark T, Alenius GM, et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis. 2014;73:407\u201313.","journal-title":"Ann Rheum Dis"},{"key":"678_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3899\/jrheum.220154","volume":"50","author":"L Gossec","year":"2023","unstructured":"Gossec L, Walsh JA, Michaud K, et al. Women with psoriatic arthritis experience higher disease burden than men: findings from a real-world survey in the United States and Europe. J Rheumatol. 2023;50:192\u20136.","journal-title":"J Rheumatol"},{"key":"678_CR23","doi-asserted-by":"publisher","first-page":"FSO369","DOI":"10.4155\/fsoa-2018-0101","volume":"5","author":"MR Ribeiro da Silva","year":"2019","unstructured":"Ribeiro da Silva MR, Ribeiro Dos Santos JB, Maciel Almeida A, et al. Medication persistence for psoriatic arthritis in a Brazilian real-world setting. Future Sci OA. 2019;5:FSO369.","journal-title":"Future Sci OA"},{"key":"678_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa070","volume":"4","author":"K Geale","year":"2020","unstructured":"Geale K, Lindberg I, Paulsson EC, et al. Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden. Rheumatol Adv Pract. 2020;4: rkaa070.","journal-title":"Rheumatol Adv Pract"},{"key":"678_CR25","first-page":"162","volume":"3","author":"D Colombo","year":"2022","unstructured":"Colombo D, Frassi M, Mariano GP, et al. The CHRONOS real-world evidence of biologic treatments in psoriatic arthritis in Italy: a post hoc gender analysis. Womens Health Rep (New Rochelle). 2022;3:162\u201371.","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"678_CR26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s40744-021-00367-z","volume":"8","author":"LC Coates","year":"2021","unstructured":"Coates LC, Azevedo VF, Cappelleri JC, et al. Exploring the quality of communication between patients with psoriatic arthritis and physicians: results of a global online survey. Rheumatol Ther. 2021;8:1741\u201358.","journal-title":"Rheumatol Ther"},{"key":"678_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79:700\u201312.","journal-title":"Ann Rheum Dis"},{"key":"678_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/acr.22401","volume":"67","author":"L Eder","year":"2015","unstructured":"Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res (Hoboken). 2015;67:264\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"678_CR29","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10067-017-3578-9","volume":"36","author":"DE Furst","year":"2017","unstructured":"Furst DE, Tran M, Sullivan E, et al. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36:2045\u201354.","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00678-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:05:39Z","timestamp":1727211939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00678-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lihi Eder has received research and educational grants from AbbVie, Eli Lilly, Fresenius Kabi, Janssen, Novartis, Pfizer Inc, Sandoz, and UCB, and has received consulting fees from AbbVie, Bristol Myers Squibb, Eli\u00a0Lilly, Janssen, Novartis, Pfizer Inc, and UCB. Pascal Richette has received consulting fees from AbbVie, Celgene, Eli Lilly, Janssen, MSD, Novartis, Pfizer Inc, and UCB. Laura C Coates is an Editorial Board member of <i>Rheumatology and Therapy<\/i>. Laura C Coates was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Laura C Coates has received research funding from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB, has received consulting fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Eli Lilly, Gilead, Galapagos, Janssen, MoonLake, Novartis, Pfizer Inc, and UCB, and has received speaker fees from AbbVie, Amgen, Biogen, Celgene, Eli Lilly, Galapagos, Gilead, GSK, Janssen, Medac, Novartis, Pfizer Inc, and UCB. Valderilio F Azevedo has received research funding from AbbVie, Bristol Myers Squibb, Eli Lilly, Genentech, GSK, Pfizer Inc, and UCB, and has received consulting and speaker fees from AbbVie, Celltrion, Eli Lilly, Janssen, Pfizer Inc, and Roche. Joseph C Cappelleri and Meriem Kessouri are employees and shareholders of Pfizer Inc. Edward P Johnson and Jade Moser are employees of The Harris Poll, which was a paid contractor to Pfizer to conduct the initial research and related statistical analysis. Megan Hoang was an intern of Pfizer Inc at the time of the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All patients provided informed consent before participating in the survey. As this was a non-interventional survey and personal data from the surveys were not identifiable, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}